Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision A Iqubal, MK Iqubal, S Sharma, MA Ansari, AK Najmi, SM Ali, J Ali, ... Life sciences, 2018 | 302 | 2018 |
Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer M Imran, MK Iqubal, K Imtiyaz, S Saleem, S Mittal, MMA Rizvi, J Ali, ... International journal of pharmaceutics 587, 119705, 2020 | 170 | 2020 |
Environmental neurotoxic pollutants A Iqubal, M Ahmed, S Ahmad, CR Sahoo, MK Iqubal, SE Haque Environmental Science and Pollution Research 27, 41175-41198, 2020 | 136 | 2020 |
Nano-based drug delivery system: recent strategies for the treatment of ocular disease and future perspective Z Qamar, FF Qizilbash, MK Iqubal, A Ali, JK Narang, J Ali, S Baboota Recent Patents on Drug Delivery & Formulation 13 (4), 246-254, 2019 | 115 | 2019 |
Combinatorial lipid-nanosystem for dermal delivery of 5-fluorouracil and resveratrol against skin cancer: Delineation of improved dermatokinetics and epidermal drug deposition … MK Iqubal, A Iqubal, K Imtiyaz, MMA Rizvi, MM Gupta, J Ali, S Baboota European Journal of Pharmaceutics and Biopharmaceutics 163, 223-239, 2021 | 80 | 2021 |
Recent Advances in Direct Compression Technique for Pharmaceutical Tablet Formulation MK Iqubal International Journal of Pharmaceutical Research and Development 6 (01), 49-57, 2014 | 69 | 2014 |
Microemulsions: current trends in novel drug delivery systems PK Singh, MK Iqubal, VK Shukla, M Shuaib Journal of Pharmaceutical, Chemical and Biological Sciences 1 (1), 39-51, 2014 | 61 | 2014 |
Trends in nanotechnology-based delivery systems for dermal targeting of drugs: An enticing approach to offset psoriasis S Saleem, MK Iqubal, S Garg, J Ali, S Baboota Expert Opinion on Drug Delivery 17 (6), 817-838, 2020 | 59 | 2020 |
Tailoring of berberine loaded transniosomes for the management of skin cancer in mice DK Gupta, M Aqil, A Ahad, SS Imam, A Waheed, A Qadir, MK Iqubal, ... Journal of Drug Delivery Science and Technology 60, 102051, 2020 | 36 | 2020 |
Intranasally administered pitavastatin ameliorates pentylenetetrazol-induced neuroinflammation, oxidative stress and cognitive dysfunction A Iqubal, S Sharma, K Sharma, A Bhavsar, I Hussain, MK Iqubal, R Kumar Life sciences 211, 172-181, 2018 | 35 | 2018 |
Gene therapy, a novel therapeutic tool for neurological disorders: current progress, challenges and future prospective A Iqubal, MK Iqubal, A Khan, J Ali, S Baboota, SE Haque Current Gene Therapy 20 (3), 184-194, 2020 | 29 | 2020 |
Nano-engineered nerolidol loaded lipid carrier delivery system attenuates cyclophosphamide neurotoxicity–Probable role of NLRP3 inflammasome and caspase-1 A Iqubal, MA Syed, AK Najmi, F Azam, GE Barreto, MK Iqubal, J Ali, ... Experimental Neurology 334, 113464, 2020 | 28 | 2020 |
Clinical updates on drug-induced cardiotoxicity A Iqubal, SE Haque, S Sharma, MA Ansari, V Khan, MK Iqubal Int. J. Pharm. Sci. Res 9 (1), 16-26, 2018 | 28 | 2018 |
Experimental hepatotoxicity inducing agents: a Review A Iqubal, MK Iqubal, SE Haque Int J Clin Pharmacol Res 6 (11), 325-35, 2016 | 28 | 2016 |
Determination of in vivo virtue of dermal targeted combinatorial lipid nanocolloidal based formulation of 5-fluorouracil and resveratrol against skin cancer MK Iqubal, A Iqubal, H Anjum, MM Gupta, J Ali, S Baboota International Journal of Pharmaceutics 610, 121179, 2021 | 26 | 2021 |
Current insight into the therapeutic potential of phytocompounds and their nanoparticle-based systems for effective management of lung cancer M Fatima, MK Iqubal, A Iqubal, H Kaur, SJ Gilani, MH Rahman, A Ahmadi, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2022 | 25 | 2022 |
COVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention A Iqubal, MK Iqubal, F Hoda, AK Najmi, SE Haque Expert Review of Anti-infective Therapy 19 (9), 1083-1092, 2021 | 24 | 2021 |
current quest in natural bioactive compounds for Alzheimer’s disease: Multi-targeted-designed-ligand based approach with preclinical and clinical based evidence A Iqubal, SO Rahman, M Ahmed, P Bansal, MR Haider, MK Iqubal, ... Current Drug Targets 22 (6), 685-720, 2021 | 21 | 2021 |
miRNAs in the regulation of cancer immune response: effect of miRNAs on cancer immunotherapy FH Pottoo, A Iqubal, MK Iqubal, M Salahuddin, JU Rahman, N AlHajri, ... Cancers 13 (23), 6145, 2021 | 20 | 2021 |
Polyphenols as potential therapeutics for pain and inflammation in spinal cord injury A Iqubal, M Ahmed, MK Iqubal, FH Pottoo, SE Haque Current Molecular Pharmacology 14 (5), 714-730, 2021 | 20 | 2021 |